Antiviral 1 Flashcards

1
Q

Nucleoside analogues

A

Acyclovir Famciclovir Valacyclovir Panciclovir Ganciclovir Valganciclovir Cidofovir Trifluridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nucleoside analogues - MoA

A

Prodrugs that are converted to monophosphate by virus enzymes, and then to active triphosphate metabolites by host enzymes. Competitive inhibition of viral DNA polymerase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acyclovir - Clinical use

A

HSV, VZV Prophylaxis of CMV Chickenpox IV form: most effective treatment for serious herpesvirus infections, including herpetic encephalitis and severe HSV and VZV infections in immunocompromised patients Topical form: herpes genitalis and mild mucocutaneous infections in immunocompromised patients. In cases of herpes genitalis, however, topical form is less effective than oral form

Herpetic encephalitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Acyclovir - Adverse effects

A

Well tolerated Headache, GI disturbances, rash (General for all the nucleoside analoges) IV: phlebitis + reversible renal dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Famciclovir - Clinical use

A

HSV VZV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Valacyclovir - Clinical use

A

HSV, VZV Prophylaxis of CMV , such as in bone marrow and organ transplant recipients and in persons with HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Panciclovir - Clinical use

A

Herpes labialis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ganciclovir - Clincal use

A

Prevent CMV diseases, including retinitis, esophagitis, and colitis HSV: keratitis (infection of the corneal epithelium) caused by HSV-1 and HSV-2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ganciclovir - Adverse effects

A

Leukopeina, thrombocytopenia Retinal detachment, liver and renal dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ganciclovir - Interactions

A

Severe myelosupression with zidovudine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Valganciclovir - Clinical use

A

Prevent and treatment of less severe CMV infections, including those occurring in renal and heart transplant patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cidofovir - Clinical use

A

Prevent CMV diseases resistant to ganciclovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cidofovir - Contraindications

A

Contraindicated in patients taking other nephrotoxic drugs, such as aminoglycosides and amphotericin B.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cidofovir - Adverse effects

A

Nephrotoxicity, neutropenia, metabolic acidosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Trifluridine - Clinical use

A

Ocular herpervirus infections, primarily herpetic epithelial keratitis and keratoconjuctivitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pyrophosphate derivative (HSV drug)

A

Foscarnet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Foscarnet - MoA

A

Blocks pyrophosphate-binding sites on viral DNA polymerase and prevents attachment of nucleotide precursor to DNA. Does not need activation by viral/host kinases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Foscarnet - Clinical use

A

CMV, VZV, HSV CMV retinitis in AIDS patients Acyclovir-resistant HSV infections Shingles Combined with ganciclovir to treat infections resistant to either drug alone because of their synergistic effect on viral DNA polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Foscarnet - Adverse effects

A

Renal impairment and acute renal failure, hematologic deficiencies, cardiac arrhythmias + heart failure, seizures, pancreatitis Renal toxicity can be minimized by administering intravenous fluids to induce diuresis before and during treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Nucleoside reverse transcriptase inhibitors (NRTIs)

A

Didanosine Lamivudine Stavudine Emtricitabine Zidovudine (ZDV) Abacivir (ABC) Tenofovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Nucleoside reverse transcriptase inhibitors (NRTIs) - MoA

A

Triphosphate metabolites of the drug compete with nucleoside triphosphates for incorporation into viral DNA. Cause DNA chain termination. Inhibit host cell DNA polymerase somewhat.

22
Q

Nucleoside reverse transcriptase inhibitors (NRTIs) - Clinical use

A

HIV Some are active for Epstein-Barr virus and hepatitis B virus

23
Q

Nucleoside reverse transcriptase inhibitors (NRTIs) - Special considerations

A

Included in almost all HIV treatment regimens. Often more effective with multiple NRTIs (antimetabolites of different bases of DNA). Cross BBB. Careful with renal impairment

24
Q

Nucleoside reverse transcriptase inhibitors (NRTIs) - Adverse effects

A

Lactic acidosis, hepatic steatosis, lipodystrophy

25
Q

First line HIV drugs

A

Abacivir (ABC) Tenofovir Emtricitabine Lamivudine

26
Q

Alternative for 1st line drugs for HIV

A

Stavudine Didanosine

27
Q

ucleoside reverse transcriptase inhibitors (NRTIs) - For treatment of hepatitis B

A

Lamivudine Tenofovir

28
Q

Which NRTI is used to treat HIV in pregnant women?

A

Zidovudine (ZDV)

29
Q

Which NRTIs are not used together and why?

A

Zidovudine and stavudine because they appear to be antagonistic

30
Q

Abacavir - Adverse effects

A

Hypersensitivity reactions

31
Q

Which NRTIs cause Pancreatitis and Peripheral neuropathy

A

Didanosine and Stavudine

32
Q

Tenofovir - Adverse effect (the most important)

A

Renal impairment

33
Q

Zidovudine - Adverse effect (the most important)

A

Bone marrow suppression

34
Q

Nonnucleoside reverse transcriptase inhibitors (NNRTIs)

A

Efavirenz Nevirapine Delavirdine

35
Q

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) - MoA

A

Direct inhibition of reverse transcriptase

36
Q

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) - Clinical use

A

HIV

37
Q

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) - Special considerations

A

Cross BBB Act synergistically with NRTIs and PIs against HIV. Never used alone for HIV

38
Q

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) - Contraindications

A

Contraindicated for hepatic impairment

39
Q

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) - Adverse effects

A

Moderately well tolerated Rash (can progress to Stevens-Johnson syndrome) Hepatotoxicity Drug interactions

40
Q

Which is the most potent NNRTI?

A

Efavirenz

41
Q

Efavirenz - Contraindications

A

Contraindicated during pregnancy

42
Q

Efavirenz - Adverse effects

A

Teratogenic Neuropsychiatric reactions

43
Q

Nevirapine - Interactions

A

Induces CYP3A4 + CYP2B6: Increases metabolism of certain drugs Increases metabolism of PIs, contraceptive steroids, other drugs

44
Q

Nevirapine - Adverse effects

A

Hepatotoxicity, rash (+Stevens-Johnson syndrome)

45
Q

Delavirdine - Special consideration

A

Usually not recommended for HIV (less potent)

46
Q

Protease inhibitors (PIs) (Most important)

A

Ritonavir Atazanavir Darunavir

47
Q

Protease inhibitors (PIs) - MoA

A

Bind HIV protease and inhibits proteolytic activity. Production of immature, noninfectious viral particles.

48
Q

Protease inhibitors (PIs) - Clinical use

A

HIV

49
Q

Protease inhibitors (PIs) - Adverse effects

A

Lipodystrophy, hyperlipidemia, insulin resistance and DM, liver dysfunction, hepatitis.

50
Q

Protease inhibitors (PIs) - Interactions

A

Inhibits metabolism of other drugs: PIs, antiarrhythmic agents, opioids, tricyclic antidepressants Nevirapine: Increase PI metabolism.